SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-23-090291
Filing Date
2023-11-28
Accepted
2023-11-27 18:01:49
Documents
1
Group Members
EXPLORATION CAPITAL GENERAL PARTNER, LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea189108-13gexplorat_fresh.htm SC 13G 49355
  Complete submission text file 0001213900-23-090291.txt   51148
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Fresh Tracks Therapeutics, Inc. (Subject) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-42755 | Film No.: 231441449
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 250 EAST 200 SOUTH FLOOR 16 SALT LAKE CITY UT 84111
Business Address 250 EAST 200 SOUTH FLOOR 16 SALT LAKE CITY UT 84111 2122204444
Exploration Capital Fund, LP (Filed by) CIK: 0001799866 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G